Wallace S, Guo D‐, Regalado E, Mellor‐Crummey L, Bamshad M, Nickerson DA, Dauser R, Hanchard N, Marom R, Martin E, Berka V, Sharina I, Ganesan V, Saunders D, Morris SA, Milewicz DM. Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension. Clinical Genetics. 2016 Feb 18;90(4):351–60. doi: 10.1111/cge.12739.